(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-6-Methyl-5-(((R)-Tetrahydro-2H-Pyran-2-Yl)Oxy)Tetrahydro-2H-Pyran-2-Yl)Oxy)-6,8,11-Trihydroxy-8-(2-Hydroxyacetyl)-1-Methoxy-7,8,9,10-Tetrahydrotetracene-5,12-Dione (8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-6-甲基-5-(((R)-四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮
CAS 72496-41-4 MFCD00869742
化学结构图
SMILES: C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O[C@H]1CCCCO1)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(C(=O)C3=CC=CC(OC)=C3C1=O)=C2O)C(=O)CO
化学属性
| Mol. Formula | C32H37NO12 |
|---|---|
| Mol. Weight | 628 |
别名和识别编码
| Chemical Name | (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-6-Methyl-5-(((R)-Tetrahydro-2H-Pyran-2-Yl)Oxy)Tetrahydro-2H-Pyran-2-Yl)Oxy)-6,8,11-Trihydroxy-8-(2-Hydroxyacetyl)-1-Methoxy-7,8,9,10-Tetrahydrotetracene-5,12-Dione |
|---|---|
| CAS Number | 72496-41-4 |
| Synonym | (8S,10S)- THP-adriamycin Pirarubicin 4'-O-Tetrahydropyranyladriamycin 1609RB 4'-O-Tetrahydropyranyldoxorubicin THP |
| MDL Number | MFCD00869742 |
| Chemical Name Translation | (8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-6-甲基-5-(((R)-四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Pharmaceuticals
- Chiral Reagents
- Intermediates & Fine Chemicals,
- {SNA} Antibiotics, Antibiotics A to Z, Antibiotics N-S, Antibiotics by Application, Antineoplastic and Immunosuppressive Antibiotics
- {SNA} Antibiotics A to Z, Antibiotics N-S, Antibiotics by Application, Antineoplastic and Immunosuppressive Antibiotics, 抗生素, 生化试剂
产品应用
- Structural analog of Doxorubicin. Antineoplastic.
相关文献及参考
- Umezawa, H., et al.: J. Antibiot., 32, 1082 (1979),
- Majima, H., et al.: Biomed. Pharmacother., 41, 237 (1987),
- Miller, A.A., et al.: Cancer Res., 47, 1461 (1987),
安全信息
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 14 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 38,167,1989
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 27800 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 32,1082,1979
TYPE OF TEST : DNA damage TEST SYSTEM : Rodent - mouse Leukocyte DOSE/DURATION : 3 mg/L REFERENCE : BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 37,1763,1988
TYPE OF TEST : DNA inhibition TEST SYSTEM : Rodent - rat Cells - not otherwise specified DOSE/DURATION : 260 ug/L REFERENCE : BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 38,167,1989
TYPE OF TEST : DNA inhibition TEST SYSTEM : Rodent - mouse Lymphocyte DOSE/DURATION : 100 ug/L REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 36,312,1983
TYPE OF TEST : DNA inhibition TEST SYSTEM : Rodent - mouse Leukocyte DOSE/DURATION : 240 ug/L REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 36,312,1983
TYPE OF TEST : Mutation test systems - not otherwise specified TEST SYSTEM : Rodent - mouse Lymphocyte DOSE/DURATION : 230 ug/L REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 36,312,1983
